Search Results - "Ní Challanaín, D."

A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 Disease by Boursnell, M. E. G., Entwisle, C., Blakeley, D., Roberts, C., Duncan, I. A., Chisholm, S. E., Martin, G. M., Jennings, R., Ní Challanaín, D., Sobek, I., Inglis, S. C., McLean, C. S.

“…A glycoprotein H (gH)-deleted herpes simplex virus type 2 (HSV-2) was evaluated as a vaccine for the prevention of HSV-induced disease. This virus, which we…”
Get full text

Induction of a protective immune response by mucosal vaccination with a DISC HSV-1 vaccine by McLean, C.S., NíChallanáin, D., Duncan, I., Boursnell, M.E.G., Jennings, R., Inglis, S.C.

“…The vaccine potential of a genetically disabled Herpes Simplex Virus Type 1 virus (DISC HSV-1) was investigated in the guinea pig model of intravaginal…”
Get full text

Protective Vaccination Against Primary And Recurrent Disease Caused By Herpes Simplex Virus (HSV) Type 2 Using A Genetically Disabled HSV-1 by Mclean, C. S., Erturk, M., Jennings, R., Ni Challanain, D., Minson, A. C., Duncan, I., Boursnell, M. E. G., Inglis, S. C.

“…The vaccine potential of a mutant herpes simplex virus (HSV) type 1, with a deletion in the glycoprotein H (gH) gene, was evaluated. The virus requires a…”
Get full text

Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1 by McLean, C S, Erturk, M, Jennings, R, Ni Challanain, D, Minson, A C, Duncan, I, Boursnell, MEG, Inglis, S C

“…The vaccine potential of a mutant herpes simplex virus (HSV) type 1, with a deletion in the glycoprotein H (gH) gene, was evaluated. The virus requires a…”
Get full text